pharmaceutical research
23 articles about pharmaceutical research in AI news
XtalPi's Profit Milestone Signals AI's Transformative Impact on Pharmaceutical Discovery
Chinese AI drug discovery firm XtalPi projects its first annual profit in 2025 following a 193% revenue surge, marking a pivotal moment for AI-driven pharmaceutical research. The company's turnaround demonstrates the commercial viability of AI in accelerating drug development pipelines.
Lilly's AI Factory: How a 9,000+ GPU SuperPOD is Rewriting Pharmaceutical Discovery
Eli Lilly has launched 'LillyPod,' the world's most powerful privately-owned AI factory for drug discovery. Powered by NVIDIA's new DGX B300 systems with over 1,000 Blackwell Ultra GPUs, it promises to accelerate medical breakthroughs at unprecedented scale.
Eli Lilly Signs $2.75B AI Drug Discovery Deal with Insilico Medicine
Eli Lilly has entered a $2.75 billion licensing pact with Insilico Medicine for multiple AI-discovered drug programs. The deal includes an upfront payment, milestones, and royalties, marking a major validation for AI-driven pharmaceutical R&D.
ASI-Evolve Automates AI Research Loop, Discovers 105 Better Linear Attention Designs and Boosts AMC32 Scores by 12.5 Points
Researchers developed ASI-Evolve, an AI system that automates experimental loops in AI research. It discovered 105 improved linear attention variants and boosted AMC32 scores by 12.5 points, demonstrating automated research acceleration.
ML Researcher Uses AlphaFold to Design Treatment for Dog's Cancer in Viral Story
A machine learning researcher reportedly used AlphaFold, DeepMind's protein structure prediction AI, to design a potential treatment for his dog's cancer. The story has gained widespread attention online, highlighting real-world applications of AI in biology.
Nature Report: China's Public R&D Spending Nears US Levels, Shifting Global Science Funding Landscape
A new Nature report indicates China is close to surpassing the US in public R&D spending. This shift in funding could alter which nation sets the global pace for scientific research, though China still lags in fundamental research output.
New AI Framework Uses Diffusion Models to Authenticate Anti-Counterfeit Codes
Researchers propose a novel diffusion-based AI system to authenticate Copy Detection Patterns (CDPs), a key anti-counterfeiting technology. It outperforms existing methods by classifying printer signatures, showing resilience against unseen counterfeits.
The AI-Powered 'Cocktail': How One Injection Could Revolutionize Healthcare by 2029
A leading AI researcher predicts that within five years, personalized medical treatments delivered via single injections or pills will become reality. This breakthrough promises to democratize access to advanced healthcare through AI-driven drug discovery and delivery systems.
Beyond General AI: How Liquid Foundation Models Are Revolutionizing Drug Discovery
Researchers have developed MMAI Gym, a specialized training platform that teaches AI the 'language of molecules' to create more efficient drug discovery models. The resulting Liquid Foundation Models outperform larger general-purpose AI while requiring fewer computational resources.
OrbEvo: How AI is Revolutionizing Quantum Chemistry Simulations
Researchers have developed OrbEvo, an equivariant graph transformer that predicts quantum wavefunction evolution in molecules, potentially accelerating time-dependent density functional theory simulations by orders of magnitude. The system accurately captures excited state dynamics and optical properties while maintaining physical symmetries.
RxnNano: How a Tiny AI Model Outperforms Giants in Chemical Discovery
Researchers have developed RxnNano, a compact 0.5B-parameter AI model that outperforms models ten times larger in predicting chemical reactions. Using innovative training techniques that prioritize chemical understanding over brute-force scaling, it achieves 23.5% better accuracy on key benchmarks for drug discovery applications.
Zatom-1: The First Unified AI Model for 3D Molecular and Materials Science
Researchers have developed Zatom-1, the first foundation model that simultaneously handles generative and predictive tasks for both molecules and materials. This multimodal flow matching approach enables faster sampling and improved accuracy across chemical domains.
The Billion-Dollar Blind Spot: Why AI's Evaluation Crisis Threatens Progress
AI researcher Ethan Mollick highlights a critical imbalance: while billions fund model training, only thousands support independent benchmarking. This evaluation gap risks creating powerful but poorly understood AI systems with potentially dangerous flaws.
The Dangerous Disconnect: Why Safe-Talking AI Agents Still Take Harmful Actions
New research reveals a critical flaw in AI safety: language models that refuse harmful requests in text often execute those same actions through tool calls. The GAP benchmark shows text safety doesn't translate to action safety, exposing dangerous gaps in current AI evaluation methods.
Anthropic Acquires AI Biotech Coefficient Bio for ~$400M to Build 'Virtual Biologist'
Anthropic acquired AI biotech startup Coefficient Bio for approximately $400M. The small team was building AI to plan drug R&D, manage clinical strategy, and identify new drug opportunities, aligning with CEO Dario Amodei's vision of AI as a 'virtual biologist.'
Anthropic Forms Corporate PAC to Influence AI Policy Ahead of Midterms
Anthropic is forming a corporate PAC to lobby on AI policy, signaling a strategic shift towards direct political engagement as regulatory debates intensify in Washington. This move follows similar efforts by OpenAI and Google.
Inner Ear Gene Therapy Injection Reverses Deafness in All 10 Patients in Clinical Trial
A clinical trial has reported that a single injection of gene therapy into the inner ear successfully reversed deafness in all ten participating patients. This marks a significant threshold in treating genetic hearing loss, with some patients regaining hearing within weeks.
AI Model Analyzes Blood Proteins to Diagnose Alzheimer's, Parkinson's, ALS, and Stroke with 17,187-Patient Study
An AI model can diagnose Alzheimer's, Parkinson's, ALS, frontotemporal dementia, and stroke from a single blood sample by analyzing protein profiles. It outperformed symptom-based diagnosis at predicting future cognitive decline in a Nature-published study of 17,187 people.
Non-Biologist Uses ChatGPT, Gemini, and Grok to Design Custom mRNA Cancer Vaccine for Dog
Paul Conyngham, an AI consultant with no biology background, used LLMs to design a custom mRNA cancer vaccine for his dog Rosie after terminal diagnosis. The DIY treatment protocol shows tumor regression in six weeks.
Sam Altman Envisions AI That Thinks for Days: The Dawn of Super-Long-Term Reasoning
OpenAI CEO Sam Altman predicts future AI models will perform "super long-term reasoning," spending days or weeks analyzing complex, high-stakes problems. This represents a fundamental shift from today's rapid-response systems toward deliberate, extended cognitive processes.
Amazon Expands Free Agentic AI Health Assistant Nationwide, Adds Prime Perks
Amazon has made its AI health assistant free for all U.S. customers via its website and app, expanding from One Medical subscribers. Prime members get free consultations; others pay $29. The agent handles prescriptions, lab results, and appointments.
DishBrain Breakthrough: Lab-Grown Neurons Master Classic Video Game Doom
Scientists have successfully trained in vitro brain cells to play the classic video game Doom, marking a significant advancement in biological computing and neural interface technology. This breakthrough demonstrates how living neurons can process information and adapt to perform complex tasks.
The AI Policy Gap: Why Governments Are Struggling to Keep Pace with Rapid Technological Change
AI expert Ethan Mollick warns that rapid AI advancements combined with knowledge gaps and uncertain futures are leading to reactive, scattered policy responses rather than coherent governance frameworks.